|
1
|
Wang R: The gasotransmitter role of
hydrogen sulfide. Antioxid Redox Signal. 5:493–501. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fiorucci S, Distrutti E, Cirino G and
Wallace JL: The emerging roles of hydrogen sulfide in the
gastrointestinal tract and liver. Gastroenterology. 131:259–271.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Szabo C: Hydrogen sulphide and its
therapeutic potential. Nat Rev Drug Discov. 6:917–935. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Szabo C: Gaseotransmitters: New frontiers
for translational science. Sci Transl Med. 2:59ps542010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Whiteman M, Le Trionnaire S, Chopra M, Fox
B and Whatmore J: Emerging role of hydrogen sulfide in health and
disease: Critical appraisal of biomarkers and pharmacological
tools. Clin Sci (Lond). 121:459–488. 2011. View Article : Google Scholar
|
|
6
|
Wang R: Physiological implications of
hydrogen sulfide: A whiff exploration that blossomed. Physiol Rev.
92:791–896. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Predmore BL, Lefer DJ and Gojon G:
Hydrogen sulfide in biochemistry and medicine. Antioxid Redox
Signal. 17:119–140. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kimura H, Shibuya N and Kimura Y: Hydrogen
sulfide is a signaling molecule and a cytoprotectant. Antioxid
Redox Signal. 17:45–57. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Esechie A, Kiss L, Olah G, et al:
Protective effect of hydrogen sulfide in a murine model of acute
lung injury induced by combined burn and smoke inhalation. Clin Sci
(Lond). 115:91–97. 2008. View Article : Google Scholar
|
|
10
|
Stuhlmeier KM, Broll J and Iliev B:
NF-kappaB independent activation of a series of proinflammatory
genes by hydrogen sulfide. Exp Biol Med (Maywood). 234:1327–1338.
2009. View Article : Google Scholar
|
|
11
|
Osipov RM, Robich MP, Feng J, et al:
Effect of hydrogen sulfide on myocardial protection in the setting
of cardioplegia and cardiopulmonary bypass. Interact Cardiovasc
Thorac Surg. 10:506–512. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Whiteman M, Li L, Rose P, Tan CH,
Parkinson DB and Moore PK: The effect of hydrogen sulfide donors on
lipopoly-saccharide-induced formation of inflammatory mediators in
macrophages. Antioxid Redox Signal. 12:1147–1154. 2010. View Article : Google Scholar :
|
|
13
|
Zhang J, Sio SW, Moochhala S and Bhatia M:
Role of hydrogen sulfide in severe burn injury-induced inflammation
in mice. Mol Med. 16:417–424. 2010.PubMed/NCBI
|
|
14
|
Zuidema MY, Peyton KJ, Fay WP, Durante W
and Korthuis RJ: Antecedent hydrogen sulfide elicits an
anti-inflammatory phenotype in postischemic murine small intestine:
Role of heme oxygenase-1. Am J Physiol Heart Circ Physiol.
301:H888–H894. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ang SF, Moochhala SM, MacAry PA and Bhatia
M: Hydrogen sulfide and neurogenic inflammation in polymicrobial
sepsis: Involvement of substance P and ERK-NF-κB signaling. PLoS
One. 6:e245352011. View Article : Google Scholar
|
|
16
|
Gao C, Xu DQ, Gao CJ, et al: An exogenous
hydrogen sulphide donor, NaHS, inhibits the nuclear factor κB
inhibitor kinase/nuclear factor κB inhibitor/nuclear factor-κB
signaling pathway and exerts cardioprotective effects in a rat
hemorrhagic shock model. Biol Pharm Bull. 35:1029–1034. 2012.
View Article : Google Scholar
|
|
17
|
Tokuda K, Kida K, Marutani E, et al:
Inhaled hydrogen sulfide prevents endotoxin-induced systemic
inflammation and improves survival by altering sulfide metabolism
in mice. Antioxid Redox Signal. 17:11–21. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang T, Wang L, Zaidi SR, et al: Hydrogen
sulfide attenuates particulate matter-induced human lung
endothelial barrier disruption via combined reactive oxygen species
scavenging and Akt activation. Am J Respir Cell Mol Biol.
47:491–496. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sen N, Paul BD, Gadalla MM, et al:
Hydrogen sulfide-linked sulfhydration of NF-κB mediates its
antiapoptotic actions. Mol Cell. 45:13–24. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chan MV and Wallace JL: Hydrogen
sulfide-based therapeutics and gastrointestinal diseases:
Translating physiology to treatments. Am J Physiol Gastrointest
Liver Physiol. 305:G467–G473. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Aslami H, Beurskens CJ, de Beer FM, et al:
A short course of infusion of a hydrogen sulfide-donor attenuates
endotoxemia induced organ injury via stimulation of
anti-inflammatory pathways, with no additional protection from
prolonged infusion. Cytokine. 61:614–621. 2013. View Article : Google Scholar
|
|
22
|
Rivers JR, Badiei A and Bhatia M: Hydrogen
sulfide as a therapeutic target for inflammation. Expert Opin Ther
Targets. 16:439–449. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Benetti LR, Campos D, Gurgueira SA,
Vercesi AE, Guedes CE, Santos KL, Wallace JL, Teixeira SA,
Florenzano J, Costa SK, Muscará MN and Ferreira HH: Hydrogen
sulfide inhibits oxidative stress in lungs from allergic mice in
vivo. Eur J Pharmacol. 698:463–469. 2013. View Article : Google Scholar
|
|
24
|
Li L, Fox B, Keeble J, et al: The complex
effects of the slow-releasing hydrogen sulfide donor GYY4137 in a
model of acute joint inflammation and in human cartilage cells. J
Cell Mol Med. 17:365–376. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hitchler MJ and Domann FE: An epigenetic
perspective on the free radical theory of development. Free Radic
Biol Med. 43:1023–1036. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fischle W, Wang Y and Allis CD: Histone
and chromatin cross-talk. Curr Opin Cell Biol. 15:172–183. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lachner M and Jenuwein T: The many faces
of histone lysine methylation. Curr Opin Cell Biol. 14:286–298.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Noland BJ, Hardin JM and Shepherd GR:
Histone acetyltransferase activity in synchronized mammalian cells.
Biochim Biophys Acta. 246:263–268. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fuks F, Hurd PJ, Deplus R and Kouzarides
T: The DNA meth-yltransferases associate with HP1 and the SUV39H1
histone methyltransferase. Nucleic Acids Res. 31:2305–2312. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Papapetropoulos A, Whiteman M and Cirino
G: Pharmacological tools for hydrogen sulphide research: a brief,
introductory guide for beginners. Br J Pharmacol. June 9–2014.Epub
ahead of print. View Article : Google Scholar
|
|
31
|
Schlesinger Y, Straussman R and Keshet I:
Polycomb-mediated methylation on Lys27 of histone H3 pre-marks
genes for de novo methylation in cancer. Nat Genet. 39:232–236.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kirmizis A, Bartley SM, Kuzmichev A, et
al: Silencing of human polycomb target genes is associated with
methylation of histone H3 Lys 27. Genes Dev. 18:1592–1605. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Saccani S and Natoli G: Dynamic changes in
histone H3 Lys 9 methylation occurring at tightly regulated
inducible inflammatory genes. Genes Dev. 16:2219–2224. 2002.
View Article : Google Scholar : PubMed/NCBI
|
